Pharmacology of motion sickness

[1] ALLEN ME, 1986, AVIAT SPACE ENVIR MD, V57, P647

[2] BRAND JJ, 1966, PHARMACOL REV, V18, P895

[3] CHELEN W, 1990, AVIAT SPACE ENVIR MD, V61, P1022

[4] INVESTIGATION OF ANTI-MOTION SICKNESS DRUGS IN THE SQUIRREL-MONKEY [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 32 (02) : 163 - 175

[5] ETIOLOGIC SIGNIFICANCE OF ARGININE-VASOPRESSIN IN MOTION SICKNESS [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 34 (06) : 664 - 670

[6] CHINN HI, 1955, PHARMACOL REV, V7, P33

[7] CHINN HI, 1950, P SOC EXP BIOL MED, V73, P218

[8] COOK L, 1954, J PHARMACOL EXP THER, V110, P12

[9] SYSTEMIC NALOXONE INCREASES THE INCIDENCE OF MOTION SICKNESS IN THE CAT [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1983, 19 (05) : 827 - 829

[10] CRAMPTON GH, 1985, AVIAT SPACE ENVIR MD, V56, P462

[1] ALLEN ME, 1986, AVIAT SPACE ENVIR MD, V57, P647

[2] BRAND JJ, 1966, PHARMACOL REV, V18, P895

[3] CHELEN W, 1990, AVIAT SPACE ENVIR MD, V61, P1022

[4] INVESTIGATION OF ANTI-MOTION SICKNESS DRUGS IN THE SQUIRREL-MONKEY [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 32 (02) : 163 - 175

[5] ETIOLOGIC SIGNIFICANCE OF ARGININE-VASOPRESSIN IN MOTION SICKNESS [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 34 (06) : 664 - 670

[6] CHINN HI, 1955, PHARMACOL REV, V7, P33

[7] CHINN HI, 1950, P SOC EXP BIOL MED, V73, P218

[8] COOK L, 1954, J PHARMACOL EXP THER, V110, P12

[9] SYSTEMIC NALOXONE INCREASES THE INCIDENCE OF MOTION SICKNESS IN THE CAT [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1983, 19 (05) : 827 - 829

[10] CRAMPTON GH, 1985, AVIAT SPACE ENVIR MD, V56, P462